Lara Valeska Maul Selected Research

Lara Valeska Maul Research Topics

6	Melanoma (Melanoma, Malignant) 12/2023 - 11/2016
3	Neoplasms (Cancer) 05/2023 - 01/2023
2	Skin Neoplasms (Skin Cancer) 02/2024 - 05/2023
2	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2023 - 06/2022
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 05/2023
1	Nevus (Nevi) 01/2023
1	Vitiligo 09/2022
1	Necrosis 06/2022
1	Premature Birth (Birth, Premature) 06/2022
1	Uveal melanoma 06/2021
1	Cryopyrin-Associated Periodic Syndromes 01/2021
1	Chronic Urticaria 01/2021
1	Fever (Fevers) 01/2021
1	Urticaria (Hives) 01/2021
1	Vasculitis (Vasculitides) 01/2021
1	Exanthema (Rash) 09/2018
1	Renal Insufficiency (Renal Failure) 12/2016
1	Basal Cell Carcinoma (Rodent Ulcer) 12/2016

2	tributyl phosphate (TBP)IBA 02/2024 - 01/2023
2	AntibodiesIBA 05/2023 - 06/2022
1	Sunscreening Agents (Sunscreens)IBA 12/2023
1	NivolumabIBA 05/2023
1	pembrolizumabIBA 05/2023
1	liquid crystal polymerIBA 01/2023
1	cyclopropapyrroloindoleIBA 09/2022
1	Certolizumab Pegol FDA Link 06/2022
1	Monoclonal AntibodiesIBA 06/2022
1	Interleukin-17 (Interleukin 17)IBA 06/2022
1	Estrogens (Estrogen)FDA Link 06/2022
1	canakinumab FDA Link 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	Histamine Antagonists (Antihistamines)IBA 01/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021
1	Interleukin-1 (Interleukin 1)IBA 01/2021
1	Ephedrine FDA LinkGeneric 09/2018
1	HhAntag691IBA 12/2016
1	InterferonsIBA 11/2016
1	Interferon alpha-2 (Roferon-A)FDA Link 11/2016